Electromedical Technologies Stock Performance
| EMED Stock | USD 0.0003 0.0001 25.00% |
On a scale of 0 to 100, Electromedical Technologies holds a performance score of 2. The firm shows a Beta (market volatility) of 2.31, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Electromedical Technologies will likely underperform. Please check Electromedical Technologies' maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Electromedical Technologies' price patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Electromedical Technologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, Electromedical Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 264.9 K |
Electromedical |
Electromedical Technologies Relative Risk vs. Return Landscape
If you would invest 0.05 in Electromedical Technologies on September 23, 2024 and sell it today you would lose (0.02) from holding Electromedical Technologies or give up 40.0% of portfolio value over 90 days. Electromedical Technologies is currently generating 0.5385% in daily expected returns and assumes 16.3568% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Electromedical, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Electromedical Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Electromedical Technologies' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Electromedical Technologies, and traders can use it to determine the average amount a Electromedical Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0329
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EMED | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.36 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.54 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Electromedical Technologies is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Electromedical Technologies by adding it to a well-diversified portfolio.
Electromedical Technologies Fundamentals Growth
Electromedical Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Electromedical Technologies, and Electromedical Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Electromedical Pink Sheet performance.
| Return On Asset | -1.36 | |||
| Operating Margin | (2.94) % | |||
| Current Valuation | 3.49 M | |||
| Shares Outstanding | 172.88 M | |||
| Price To Sales | 1.53 X | |||
| Revenue | 907.36 K | |||
| EBITDA | (5.14 M) | |||
| Cash And Equivalents | 65.23 K | |||
| Total Debt | 673.28 K | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.19 M) | |||
| Earnings Per Share | (0.15) X | |||
| Total Asset | 1.4 M | |||
| Retained Earnings | (91.42 M) | |||
| Current Asset | 441 K | |||
| Current Liabilities | 3.9 M | |||
About Electromedical Technologies Performance
By analyzing Electromedical Technologies' fundamental ratios, stakeholders can gain valuable insights into Electromedical Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Electromedical Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Electromedical Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company was founded in 2002 and is headquartered in Scottsdale, Arizona. Electromedical Technologies operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 7 people.Things to note about Electromedical Technologies performance evaluation
Checking the ongoing alerts about Electromedical Technologies for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Electromedical Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Electromedical Technologies is way too risky over 90 days horizon | |
| Electromedical Technologies has some characteristics of a very speculative penny stock | |
| Electromedical Technologies appears to be risky and price may revert if volatility continues | |
| Electromedical Technologies currently holds 673.28 K in liabilities. Electromedical Technologies has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Electromedical Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Electromedical Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Electromedical Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Electromedical to invest in growth at high rates of return. When we think about Electromedical Technologies' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 907.36 K. Net Loss for the year was (8.48 M) with profit before overhead, payroll, taxes, and interest of 708.13 K. | |
| Electromedical Technologies currently holds about 65.23 K in cash with (1.19 M) of positive cash flow from operations. |
- Analyzing Electromedical Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Electromedical Technologies' stock is overvalued or undervalued compared to its peers.
- Examining Electromedical Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Electromedical Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Electromedical Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Electromedical Technologies' pink sheet. These opinions can provide insight into Electromedical Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Electromedical Pink Sheet analysis
When running Electromedical Technologies' price analysis, check to measure Electromedical Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromedical Technologies is operating at the current time. Most of Electromedical Technologies' value examination focuses on studying past and present price action to predict the probability of Electromedical Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromedical Technologies' price. Additionally, you may evaluate how the addition of Electromedical Technologies to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets |